Harvest Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,745
Closed -$8.65M 824
2021
Q2
$8.65M Hold
24,745
0.92% 22
2021
Q1
$8.61M Sell
24,745
-5,083
-17% -$1.68M 0.83% 24
2020
Q4
$7.71M Buy
29,828
+1,105
+4% +$304K 0.67% 23
2020
Q3
$8.79M Buy
+28,723
New +$6.75M 0.73% 22
2019
Q1
Sell
-100,000
Closed -$14M 401
2018
Q4
$14M Hold
100,000
2.94% 11
2018
Q3
$17.2M Hold
100,000
2.96% 10
2018
Q2
$15.4M Buy
100,000
+90,000
+900% +$16.1M 2.44% 10
2018
Q1
$1.68M Buy
+10,000
New +$1.35M 0.27% 23

Other funds holding ONC

Harvest Fund Management's ONC Position: Q3 2021 in Review

Harvest Fund Management sold out of BeOne Medicines Ltd (ONC) in Q3 2021, closing a stake of 24,745 shares — an estimated $8.65M sold.

Harvest Fund Management first reported a position in ONC in Q1 2018 and held it in 8 quarters. The position peaked at $17.2M in Q3 2018. 254 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • Harvest Fund Management reported no remaining BeOne Medicines Ltd position as of Q3 2021 after selling out during the quarter.
  • Harvest Fund Management sold 24,745 BeOne Medicines Ltd shares in Q3 2021, an estimated $8.65M.
  • Harvest Fund Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 8 quarters.
  • Harvest Fund Management's BeOne Medicines Ltd position peaked at $17.2M in Q3 2018.
  • 254 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Harvest Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.